scholarly article | Q13442814 |
P50 | author | Jane W. Newburger | Q47173730 |
P2093 | author name string | Jane C Burns | |
Larry M Baddour | |||
Ann F Bolger | |||
Stanford T Shulman | |||
Kathryn A Taubert | |||
Michael A Gerber | |||
Robert S Baltimore | |||
Patricia Ferrieri | |||
Donald A Falace | |||
Masato Takahashi | |||
Walter R Wilson | |||
Michael H Gewitz | |||
Lloyd Y Tani | |||
Matthew E Levison | |||
Thomas J Pallasch | |||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Kawasaki disease | Q265936 |
cardiovascular disease | Q389735 | ||
rheumatic fever | Q753904 | ||
P304 | page(s) | 2747-71 | |
P577 | publication date | 2004-10-26 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association | |
P478 | volume | 110 |
Q36329296 | A 15-year review of children with Kawasaki's Syndrome having general anesthesia or deep sedation |
Q35628241 | A 19 year old with Fever, rash, and conjunctivitis: a connection with the heart |
Q47344620 | A 21-Month-Old Male With Refusal to Walk, Rash, and Weight Loss |
Q80530967 | A 21-year-old male with reduced left ventricular function |
Q52983124 | A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease? |
Q36668752 | A Case of Atypical Kawasaki Disease With Myositis |
Q41168340 | A Case of Kawasaki Disease With Concomitant Leptospirosis |
Q40194976 | A Case of Kawasaki Disease with Coronary Aneurysm Responding to the 4th IVIG Treatment |
Q41380014 | A Child With Kawasaki Disease and Yersinia enterocolitica Infection: A Closer Look at Pathogenesis |
Q39655163 | A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses |
Q48277378 | A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease |
Q89534232 | A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis |
Q43793777 | A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease |
Q92542275 | A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old |
Q58765263 | A case of Henoch-Schonlein Purpura with dilated coronary arteries |
Q55005085 | A case of Kawasaki disease masked by pustular type psoriasiform eruptions. |
Q40061229 | A case of atypical Kawasaki disease with giant coronary artery aneurysm containing thrombus |
Q41105109 | A case of early development of giant coronary artery aneurysms after drug-eluting stents implantation: An unpredictable menace |
Q55057339 | A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease. |
Q34005103 | A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis |
Q38601519 | A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease. |
Q29417090 | A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease |
Q38846437 | A male infant had subdural effusion and paroxysmal supraventricular tachycardia during the febrile episode of Kawasaki disease: a case report and literature review |
Q35772471 | A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease |
Q37152274 | A non-discrete method for computation of residence time in fluid mechanics simulations |
Q34874251 | A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease |
Q34498652 | A study of cardiovascular miRNA biomarkers for Kawasaki disease. |
Q30713533 | A systematic review of validated methods for identifying Kawasaki disease using administrative or claims data |
Q58604070 | ABCC4 Variants Modify Susceptibility to Kawasaki Disease in a Southern Chinese Population |
Q92184027 | Aberrant expression of serum circANRIL and hsa_circ_0123996 in children with Kawasaki disease |
Q40043358 | Acetylsalicylic acid for children with Kawasaki disease |
Q39085593 | Acquired and congenital coronary artery abnormalities |
Q38042869 | Acquired coronary disease in children: the role of multimodality imaging |
Q33276712 | Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease |
Q24682484 | Acute Kawasaki disease: not just for kids |
Q99402680 | Acute Myocardial Infarction in a 17-year-old High-school Girl |
Q54102172 | Acute kidney injury occurs only rarely in patients with Kawasaki disease. |
Q91865976 | Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease |
Q35495033 | Adult Kawasaki disease in a European patient: a case report and review of the literature |
Q45341752 | Adult Kawasaki-like syndrome with eosinophilia and tenosynovitis in a patient with human immunodeficiency virus infection. |
Q38134469 | Advances in noninvasive imaging in pediatric cardiology |
Q53422735 | Afebrile Kawasaki disease with coronary artery dilatation. |
Q33946142 | Affects of "age at diagnosis" on coronary artery lesions in patients with incomplete kawasaki disease |
Q98944934 | Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease |
Q37738895 | Ambient Air Pollutant Exposures and Hospitalization for Kawasaki Disease in Taiwan: A Case-Crossover Study (2000-2010). |
Q61806917 | An Angiotensinogen Gene Polymorphism (rs5050) Is Associated with the Risk of Coronary Artery Aneurysm in Southern Chinese Children with Kawasaki Disease |
Q37798809 | An Overview of Surgery Options for Congenital Coronary Artery Anomalies |
Q40281545 | An atypical presentation of Kawasaki disease: a 10-year-old boy with acute exudative tonsillitis and bilateral cervical lymphadenitis |
Q34486951 | An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study |
Q80639955 | An exercise tissue Doppler and strain rate imaging study of diastolic myocardial dysfunction after Kawasaki syndrome in childhood |
Q98613608 | Analysis of Circular RNAs in the Coronary Arteries of Patients with Kawasaki Disease |
Q41451230 | Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis |
Q47230629 | Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients |
Q39247857 | Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker |
Q42736402 | Aneurysm of the Left Coronary Artery in Postoperative Bland-White-Garland Syndrome |
Q53699543 | Aneurysmal coronary artery disease: An overview. |
Q91905915 | Answer to Picture Quiz |
Q54511046 | Anti-inflammatory effects of high-dose IgG on TNF-α-activated human coronary artery endothelial cells. |
Q40036899 | Anti-platelet agents in pediatric cardiac practice |
Q97526980 | Antibodies and Immunity During Kawasaki Disease |
Q47287596 | Antibody Profiling of Kawasaki Disease Using Escherichia coli Proteome Microarrays. |
Q35752608 | Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. |
Q38169556 | Appendicitis as the presenting manifestation of Kawasaki disease |
Q48272278 | Application of 2- and 3-Dimensional Sonography Using the Virtual Organ Computer-Aided Analysis Technique to Measure the Hippocampal Formation and Its Correlation With Corrected Gestational Age in Neonates |
Q30446491 | Application of prospective ECG-triggered dual-source CT coronary angiography for infants and children with coronary artery aneurysms due to Kawasaki disease |
Q87206709 | Ascending Aorta Elastography After Kawasaki Disease Compared to Systemic Hypertension |
Q38760442 | Aspiration thrombectomy and intracoronary tirofiban via GuideLiner® catheter for a thrombosed aneurysmal vessel |
Q38176141 | Aspirin for cardioprotection and strategies to improve patient adherence |
Q90273129 | Assessing left ventricular systolic function in children with a history of Kawasaki disease |
Q40305032 | Assessment of risk factors for Korean children with Kawasaki disease |
Q53154505 | Assessment of the relationship between coronary artery ectasia and erectile function score. |
Q37349659 | Associated symptoms in the ten days before diagnosis of Kawasaki disease |
Q24620972 | Associated symptoms of kawasaki disease |
Q50352459 | Association Between Atypical/Incomplete Kawasaki Disease and Sensorineural Hearing Loss: A Case Report |
Q33628015 | Association between Kawasaki disease and autism: a population-based study in Taiwan |
Q91638700 | Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients |
Q92030421 | Association between maternal age and outcomes in Kawasaki disease patients |
Q47957321 | Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study |
Q24627845 | Association of Kawasaki disease with tropospheric wind patterns |
Q37232037 | Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease |
Q92825438 | Association of the IL16 Asn1147Lys polymorphism with intravenous immunoglobulin resistance in Kawasaki disease |
Q35915520 | Association of the resistin gene promoter region polymorphism with Kawasaki disease in Chinese children |
Q49270156 | Atypical Kawasaki Disease Presenting with Hemiparesis and Aphasia: A Case Report |
Q43974058 | Atypical Kawasaki disease |
Q82674134 | Atypical Kawasaki disease--a clinical challenge |
Q46615289 | Atypical and incomplete Kawasaki disease |
Q58809663 | Authors' response to ‘Aspirin dose for treatment of Kawasaki disease’ |
Q53080610 | Autoimmune sclerosing cholangitis: An atypical association with kawasaki disease. |
Q36445566 | Axillary, Oral and Rectal Routes of Temperature Measurement During Treatment of Acute Kawasaki Disease |
Q40111745 | Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease |
Q64099353 | Breastfeeding and vitamin D supplementation reduce the risk of Kawasaki disease in a German population-based case-control study |
Q38716455 | Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes |
Q50022881 | C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: a differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease |
Q58914810 | CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population |
Q46401492 | CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract-Induced Murine Model of Kawasaki Disease |
Q87453680 | CD84 is markedly up-regulated in Kawasaki disease arteriopathy |
Q36499266 | CMR in inflammatory vasculitis |
Q98578687 | COVID-19 and multisystem inflammatory syndrome in children and adolescents |
Q35360944 | CT analysis of retropharyngeal abnormality in Kawasaki disease |
Q36731339 | Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. |
Q34300909 | Calcium scoring in patients with a history of Kawasaki disease |
Q26829091 | Can Coronary Artery Involvement in Kawasaki Disease be Predicted? |
Q38071996 | Can a systems biology approach unlock the mysteries of Kawasaki disease? |
Q38517828 | Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). |
Q84967206 | Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction |
Q40164908 | Cardiac Complications in 38 Cases of Kawasaki Disease with Coronary Artery Aneurysm Diagnosed by Echocardiography |
Q36365849 | Cardiac involvement in Kawasaki disease in Pakistani children |
Q35658781 | Cardiovascular biomarkers in acute Kawasaki disease |
Q40398208 | Cardiovascular complications associated with chronic active Epstein-Barr virus infection |
Q36307967 | Cardiovascular imaging in children and adults following Kawasaki disease |
Q39654279 | Cardiovascular involvement in Kawaski Disease |
Q79233367 | Cardiovascular risk factors in adolescents |
Q36209060 | Cardiovascular status after Kawasaki disease in the UK. |
Q40185952 | Case 2: A three-year-old boy with fever and neck pain |
Q40471329 | Case 2: fever, rash and pulmonary involvement. Diagnosis: Kawasaki disease. |
Q48286968 | Catheter-based anatomic and functional assessment of coronary arteries in anomalous aortic origin of a coronary artery, myocardial bridges and Kawasaki disease |
Q52983514 | Cervical ultrasound and computed tomography of Kawasaki disease: Comparison with lymphadenitis. |
Q26827088 | Challenges and priorities for research: a report from the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH) Working Group on thrombosis in pediatric cardiology and congenital heart disease |
Q91496816 | Changes in and significance of platelet function and parameters in Kawasaki disease |
Q40323125 | Characteristics of Kawasaki disease in older children |
Q57492609 | Characterization of coronary artery pathological formations from OCT imaging using deep learning |
Q28219158 | Chronic granulomatous disease associated with atypical Kawasaki disease |
Q53211466 | Chronic total occlusion by stent fracture in Kawasaki disease: is recanalisation possible? |
Q39534720 | Clinical Characteristics of Kawasaki Disease in Infants Younger than Six Months: A Single-Center Study |
Q47804715 | Clinical Manifestations of Kawasaki Disease Shock Syndrome |
Q90694982 | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study |
Q40371701 | Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey |
Q34628819 | Clinical and epidemiological characteristics of kawasaki disease. |
Q37626123 | Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology. |
Q58333188 | Clinical features of acute kidney injury in patients with Kawasaki disease |
Q45204723 | Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. |
Q37239530 | Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities |
Q50784170 | Clinical spectrum of incomplete Kawasaki disease in Thailand. |
Q35609014 | Clinical use of aspirin in treatment and prevention of cardiovascular disease |
Q33619503 | Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children |
Q42922418 | Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete kawasaki disease. |
Q53440355 | Coding single-nucleotide polymorphisms of interleukin-1 gene cluster are not associated with Kawasaki disease in the Korean population. |
Q35144681 | Common carotid artery intima-media thickness is useful for diagnosis of the acute stage of Kawasaki disease |
Q40189017 | Common variants in the CRP promoter are associated with a high C-reactive protein level in Kawasaki disease |
Q33424419 | Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin |
Q40304052 | Complete and incomplete Kawasaki disease: two sides of the same coin |
Q45279216 | Comprehensive evaluation of a patient with Kawasaki disease and giant coronary aneurysms with cardiac magnetic resonance. |
Q34081277 | Concomitant respiratory viral infections in children with Kawasaki disease. |
Q26776097 | Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean Kawasaki Disease Genetics Consortium |
Q49873428 | Controversies in diagnosis and management of Kawasaki disease |
Q93028984 | Coronary Artery Aneurysms and Thrombosis in Kawasaki Disease |
Q30234397 | Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment |
Q39218092 | Coronary Artery Anomalies: When You Need to Worry |
Q56112189 | Coronary Artery Dilatation in Toxic Shock-Like Syndrome: The Kawasaki Disease Shock Syndrome |
Q40732093 | Coronary Artery Dilatation in Viral Myocarditis Mimics Coronary Artery Findings in Kawasaki Disease |
Q42185155 | Coronary and intracerebral arterial aneurysms in a young adult with acute coronary syndrome |
Q83644760 | Coronary and systemic aneurysms in an infant with Kawasaki disease |
Q37776155 | Coronary aneurysm and silent myocardial infarction in an adolescent secondary to undiagnosed childhood Kawasaki disease. |
Q45202431 | Coronary arterial ectasia in a 2-year-old boy showing two symptoms of Kawasaki disease without manifesting fever |
Q43619242 | Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography |
Q33421535 | Coronary artery aneurysm presenting as a large mass encroaching on the right atrium in an adult patient with untreated Kawasaki disease |
Q50057626 | Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China |
Q42132996 | Coronary artery aneurysms in a 15-year-old boy. |
Q38081856 | Coronary artery aneurysms: case report and review of transcatheter management strategies |
Q92717281 | Coronary artery assessment in Kawasaki disease with dual-source CT angiography to uncover vascular pathology |
Q37472060 | Coronary artery bypass grafting for coronary artery stenosis caused by Kawasaki disease |
Q51072500 | Coronary artery indexed diameter and z score regression equations in healthy Chinese Han children. |
Q30458157 | Coronary artery involvement in pediatric Takayasu's arteritis: Case report and literature review |
Q82904473 | Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan |
Q35821679 | Coronary artery size and origin imaging in children: a comparative study of MRI and trans-thoracic echocardiography |
Q35204034 | Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre |
Q38316327 | Coronary artery thrombus resulting in sudden cardiac death in an infant with Kawasaki disease and giant coronary artery aneurysms |
Q48909732 | Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease. |
Q41613086 | Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease |
Q36797800 | Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease |
Q37585123 | Corticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature |
Q24194653 | Corticosteroids for the treatment of Kawasaki disease in children |
Q36262749 | Corticosteroids for the treatment of Kawasaki disease in children. |
Q26765479 | Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome |
Q37007652 | Current perspectives on ophthalmic manifestations of childhood rheumatic diseases |
Q50482611 | Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. |
Q42185658 | DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease |
Q92573217 | Decreased DNA methyltransferases expression is associated with coronary artery lesion formation in Kawasaki disease |
Q61800095 | Decreased Steroid Hormone Receptor Expression in Kawasaki Disease Before IVIG Treatment |
Q42031240 | Deep feature learning for automatic tissue classification of coronary artery using optical coherence tomography |
Q33846481 | Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome |
Q40324862 | Delayed diagnosis of Kawasaki disease: risk factors and outcome of treatment |
Q99565287 | Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease |
Q53721037 | Development of Kawasaki disease in a patient with PFAPA. |
Q38630748 | Development of an algorithm for the management of cervical lymphadenopathy in children: consensus of the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Society of Pediatric Infectious Diseases and the Italian Society o |
Q64960713 | Diagnosing Incomplete Kawasaki Disease. |
Q56880528 | Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature |
Q48315964 | Diagnosis of Kawasaki disease |
Q42557070 | Diagnosis of incomplete kawasaki disease in infants based on an inflammation at the bacille calmette-guérin inoculation site |
Q28191466 | Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience |
Q39160330 | Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease. |
Q36123376 | Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children |
Q34618655 | Differential expression of miR-145 in children with Kawasaki disease |
Q40066217 | Difficult diagnosis of atypical kawasaki disease in an infant younger than six months: a case report. |
Q40312655 | Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins |
Q35118513 | Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran |
Q37187114 | Dual antiplatelet therapy with clopidogrel and aspirin |
Q88096896 | Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease |
Q30969802 | Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease. |
Q40166091 | Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance |
Q36323370 | Early Detection of Kawasaki Disease in Infants. |
Q41772293 | Echocardiographic Evaluation of Coronary Abnormalities and Cardiac Function in a Murine Model of Kawasaki Disease Using High-frequency Ultrasound |
Q55446513 | Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial. |
Q40430234 | Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin |
Q92218380 | Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis |
Q92137694 | Emergence and Characterization of Acute Coronary Syndrome in Adults After Confirmed or Missed History of Kawasaki Disease in Japan: A Japanese Nationwide Survey |
Q42857022 | Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones |
Q90240804 | Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017 |
Q34112495 | Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan |
Q36949257 | Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience |
Q47636282 | Epidemiological trends of Kawasaki disease among paediatric patients admitted to the Wendy Fitzwilliam Paediatric Hospital, Trinidad, during 2004-2007. |
Q38012529 | Epidemiology and management of Kawasaki disease |
Q39456935 | Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period |
Q37234284 | Epidemiology of Kawasaki disease in Asia, Europe, and the United States |
Q54945663 | Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease. |
Q42010551 | Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease |
Q34428807 | Erythema at BCG Inoculation Site in Kawasaki Disease Patients |
Q37129983 | Establishment of Kawasaki disease database based on metadata standard |
Q36513183 | Ethnic Kawasaki Disease Risk Associated with Blood Mercury and Cadmium in U.S. Children |
Q34785741 | Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance |
Q87498901 | Evaluation of echogenicity of the heart in Kawasaki disease |
Q81139189 | Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease |
Q37589256 | Evidence of Microvascular Changes in the Retina following Kawasaki Disease |
Q35569106 | Evolution of laboratory values in patients with Kawasaki disease |
Q41756575 | Exploring the genes associated with the response to intravenous immunoglobulin in patients with Kawasaki disease using DNA microarray analysis |
Q83454274 | Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease |
Q35673684 | FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease. |
Q92812905 | Facial nerve palsy presenting as rare neurological complication of Kawasaki disease: A case report |
Q47368744 | Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014. |
Q43838083 | Factors associated with low moderate-to-vigorous physical activity levels in pediatric patients with Kawasaki disease |
Q64292449 | Familial Mediterranean Fever Gene Mutations and Gout as an Auto-Inflammatory Arthropathy |
Q34021290 | Familial occurrence of Kawasaki syndrome in North America |
Q34024542 | Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. |
Q40073272 | Fever and a Morbilliform Rash |
Q40058181 | Fever without a source: evolution of a diagnosis from Kawasaki disease to acute myelogenous leukaemia. |
Q80821449 | First recanalization of a coronary artery chronic total obstruction in an 11-year-old child with Kawasaki disease sequelae using the CROSSER catheter |
Q48835164 | Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification |
Q89373826 | Gastrointestinal involvement in Kawasaki disease: a case report |
Q92190882 | Gene Polymorphism of Aspirin-Induced Urticaria in Children With Kawasaki Disease |
Q33883840 | Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection |
Q35855926 | Gene-Gene Associations with the Susceptibility of Kawasaki Disease and Coronary Artery Lesions |
Q36465545 | Gene-expression patterns reveal underlying biological processes in Kawasaki disease |
Q33566136 | Genetic polymorphisms in Kawasaki disease |
Q24624734 | Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease |
Q84416881 | Genetics insights into the pathogenesis of Kawasaki disease |
Q29417017 | Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease |
Q61445186 | Genome-wide transcriptome analysis to further understand neutrophil activation and lncRNA transcript profiles in Kawasaki disease |
Q89458577 | Giant Thrombotic Right Coronary Aneurysm in an Infant with Undiagnosed Incomplete Kawasaki Disease and Rapidly Progressive Cardiovascular Collapse |
Q83176729 | Giant coronary and systemic aneurysms of Kawasaki disease in an infant |
Q53350804 | Giant coronary aneurysm in adult Kawasaki disease: angiographic, 64-slice coronary MDCT and cardiac MRI appearances. |
Q83097313 | Giant coronary aneurysms caused by Kawasaki disease |
Q42737071 | Giant coronary artery aneurysm following Kawasaki disease: follow-up by various cardiac imaging modalities |
Q39676543 | Giant coronary artery aneurysm with a thrombus secondary to Kawasaki disease |
Q45709876 | Giant coronary artery aneurysms in Kawasaki disease: the cost of a missed diagnosis |
Q58543347 | Giant right coronary artery aneurysm secondary to Kawasaki disease in an infant |
Q43239390 | Giant right coronary artery aneurysm secondary to Kawasaki disease in child: a case report |
Q41601611 | Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm |
Q54144614 | Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). |
Q51149871 | HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease. |
Q38609844 | Health impact of childhood and adolescent soy consumption |
Q22306347 | Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee |
Q22306345 | Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association |
Q22241921 | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association |
Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
Q29547236 | Heart disease and stroke statistics--2011 update: a report from the American Heart Association |
Q29547909 | Heart disease and stroke statistics--2012 update: a report from the American Heart Association |
Q35096658 | Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children. |
Q38837772 | High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease |
Q58598815 | High antistreptolysin O titer is associated with coronary artery lesions in patients with Kawasaki disease |
Q28396984 | High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease |
Q34641944 | High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study |
Q44734284 | Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease |
Q37459020 | Hoarseness as a presenting sign in children with Kawasaki disease |
Q33924807 | Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease |
Q36326783 | IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β |
Q34047318 | IL-31 associated with coronary artery lesion formation in Kawasaki disease |
Q47108668 | ITPKC and SLC11A1 Gene Polymorphisms and Gene-Gene Interactions in Korean Patients with Kawasaki Disease. |
Q38869612 | Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis |
Q50991494 | Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis. |
Q57301222 | Identification of LEF1 as a Susceptibility Locus for Kawasaki Disease in Patients Younger than 6 Months of Age |
Q93012659 | Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis |
Q53672027 | Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array. |
Q49188517 | Identification of differentially expressed microRNAs in acute Kawasaki disease |
Q41863276 | Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease |
Q46595474 | Image-based modeling of hemodynamics in coronary artery aneurysms caused by Kawasaki disease |
Q38551736 | Imaging of systemic vasculitis in childhood |
Q36905998 | Imaging studies in the diagnosis and management of vasculitis |
Q55280563 | Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease. |
Q38842992 | Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity |
Q35193974 | Immunoglobulin Resistance in Kawasaki Disease |
Q87258695 | Importance of evaluation of the right coronary artery by two-dimensional echocardiography in patients after Kawasaki disease: a right parasternal approach |
Q43818328 | Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease |
Q35602584 | Imputation of class I and II HLA loci using high-density SNPs from ImmunoChip and their associations with Kawasaki disease in family-based study |
Q36997642 | Incidence Rate and Epidemiological and Clinical Aspects of Kawasaki Disease in Children of Maghrebi Origin in the Province of Quebec, Canada, Compared to the Country of Origin |
Q40235964 | Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: A case report |
Q40271742 | Incomplete Kawasaki disease followed by systemic onset juvenile idiopathic arthritis- the diagnostic dilemma. |
Q40419265 | Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor |
Q38620770 | Incomplete Kawasaki disease induced by measles in a 6-month-old male infant |
Q42414114 | Incomplete Kawasaki disease: The usefulness of BCG reactivation as a diagnostic tool |
Q41935364 | Incomplete Kawasaki disease: early findings consist of congestive heart failure due to valvular heart disease |
Q42706164 | Incomplete Kawasaki disease: not to be forgotten |
Q40389269 | Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome |
Q64882658 | Incomplete Refractory Kawasaki Disease in an Infant-A Case Report and a Review of the Literature. |
Q28222748 | Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab |
Q43809703 | Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis |
Q43246556 | Incomplete kawasaki disease in an elderly man. |
Q40373887 | Incomplete, atypical kawasaki disease or evolving systemic juvenile idiopathic arthritis: a case report |
Q64081934 | Increase expression of CD177 in Kawasaki disease |
Q37166692 | Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan |
Q83576484 | Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease |
Q45161770 | Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients |
Q40216635 | Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial |
Q34021198 | Infliximab treatment for refractory kawasaki disease in korean children. |
Q33798966 | Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease |
Q52564165 | Influence of Latitude on the Prevalence of Kawasaki Disease: A Retrospective Cohort Study from the Taiwan National Health Insurance Database and Review of the Literature. |
Q39825109 | Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease |
Q44568677 | Initial intravenous gamma-globulin treatment failure in Iranian children with Kawasaki disease |
Q49980459 | Innate immune responses following Kawasaki disease and toxic shock syndrome. |
Q40086687 | Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki Disease |
Q24633011 | Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease |
Q36601910 | Interleukin-21 receptor gene polymorphisms in kawasaki disease |
Q91075915 | Internal iliac artery thrombosis in a 2-month-old infant with incomplete Kawasaki disease |
Q35955607 | Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs |
Q33405903 | Intravenous immunoglobulin therapy: how does IgG modulate the immune system? |
Q80772612 | Intravenous pulsed corticosteroid therapy for primary treatment of Kawasaki disease |
Q34544046 | Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease |
Q43274889 | Involvement of tryptophan hydroxylase 2 (TPH2) gene polymorphisms in susceptibility to coronary artery lesions in Korean children with Kawasaki disease |
Q47438817 | Is Kawasaki disease an infectious disorder? |
Q36774715 | Is high-dose aspirin necessary in the acute phase of kawasaki disease? |
Q90455679 | Kawasaki Disease |
Q90445229 | Kawasaki Disease Complicated with Cerebral Vasculitis and Severe Encephalitis |
Q41893335 | Kawasaki Disease Presenting as Acute Intestinal Obstruction |
Q89967273 | Kawasaki Disease in Children Older Than 10 Years: A Clinical Experience From Northwest India |
Q34954126 | Kawasaki Disease in Ghana: Case Reports from Korle Bu Teaching Hospital |
Q37458396 | Kawasaki Disease update |
Q89868215 | Kawasaki Disease: Global Burden and Genetic Background |
Q38591900 | Kawasaki Disease: Issues in Diagnosis and Treatment--A Developing Country Perspective |
Q28222919 | Kawasaki disease |
Q91908250 | Kawasaki disease - A common childhood vasculitis |
Q53699546 | Kawasaki disease among Egyptian children: A case series. |
Q38734917 | Kawasaki disease and cardiovascular risk: a comprehensive review of subclinical vascular changes in the longer term |
Q38638912 | Kawasaki disease and coronary artery aneurysms: from childhood to adulthood |
Q64884960 | Kawasaki disease and familial mediterranean fever gene mutations, is there any link? |
Q34632880 | Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study |
Q37243549 | Kawasaki disease associated with Mycoplasma pneumoniae |
Q43184929 | Kawasaki disease causing giant saccular aneurysms of the coronary arteries: echocardiographic and 64-slice computed tomographic angiographic findings. |
Q64247584 | Kawasaki disease complicating bilateral facial nerve palsy and giant coronary artery aneurysms: A case report |
Q28073137 | Kawasaki disease for dermatologists |
Q37953978 | Kawasaki disease in Jordan: demographics, presentation, and outcome |
Q37506277 | Kawasaki disease in Mongolia: results from 2 nationwide retrospective surveys, 1996-2008. |
Q37390888 | Kawasaki disease in Sicily: clinical description and markers of disease severity. |
Q40125408 | Kawasaki disease in a healthcare provider: an adult case in a paediatric resident |
Q35569102 | Kawasaki disease in monozygotic twins |
Q40635875 | Kawasaki disease incidence at Chandigarh, North India, during 2009-2014. |
Q42265896 | Kawasaki disease resembling acute colitis |
Q60920531 | Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition |
Q90028850 | Kawasaki disease with giant aneurysm of left coronary artery and complete occlusion of right coronary artery |
Q34549795 | Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms |
Q89736529 | Kawasaki disease: Clinico-laboratory spectrum and outcome in a cohort of children treated at a tertiary care hospital in Islamabad, Pakistan |
Q40054079 | Kawasaki disease: Medical therapies |
Q40054066 | Kawasaki disease: State of the art. |
Q38627718 | Kawasaki disease: a comprehensive review of treatment options. |
Q30249349 | Kawasaki disease: a matter of innate immunity. |
Q53162767 | Kawasaki disease: a rare case of diffuse coronary involvement. |
Q30470372 | Kawasaki disease: a review with emphasis on cardiovascular complications |
Q40276542 | Kawasaki disease: always straight to the heart? |
Q36790385 | Kawasaki disease: an epidemiological study in central Italy |
Q38945126 | Kawasaki disease: etiopathogenesis and novel treatment strategies |
Q37000664 | Kawasaki disease: four case reports of cardiopathy with an institutional and literature review |
Q38439648 | Kawasaki disease: insights into pathogenesis and approaches to treatment |
Q95840421 | Kawasaki disease: pathophysiology and insights from mouse models |
Q57795961 | Kawasaki disease: two case reports from the Aga Khan Hospital, Dar es Salaam-Tanzania |
Q87451318 | Kawasaki disease: unusual clinical manifestations |
Q35184950 | Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas |
Q27009431 | Kidney and urinary tract involvement in kawasaki disease |
Q55317014 | Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome. |
Q54545150 | Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children. |
Q37071574 | Late development of coronary artery abnormalities could be associated with persistence of non-fever symptoms in Kawasaki disease |
Q87226167 | Late symptomatic myocarditis in Kawasaki disease: an unusual manifestation |
Q51554654 | Left ventricular non-compaction revealed by aortic regurgitation due to Kawasaki disease in a boy with LDB3 mutation. |
Q34395917 | Lipoprotein particle concentrations in children and adults following Kawasaki disease |
Q53085709 | Lone aspiration thrombectomy without stenting for a patient with ST-segment elevation myocardial infarction associated with coronary ectasia. |
Q41190916 | Long-Term Prognosis for Patients with Kawasaki Disease Complicated by Large Coronary Aneurysm (diameter ≥6 mm). |
Q44215704 | Long-term evaluation of endothelial function in Kawasaki disease patients |
Q45981768 | Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions. |
Q55428714 | Long-term outcome of coronary artery dilatation in Kawasaki disease. |
Q36798211 | Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease |
Q91856923 | Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study |
Q93266106 | Lymphocyte hydrogen sulfide production predicts intravenous immunoglobulin resistance in children with Kawasaki disease: A preliminary, single-center, case-control study |
Q38644813 | Making a Case for Pediatric Antimicrobial Stewardship Programs |
Q91908310 | Maladie de Kawasaki |
Q41493083 | Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease |
Q37465500 | Management of Kawasaki disease |
Q58921960 | Management of Kawasaki disease: corticosteroids revisited |
Q36344968 | Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease |
Q34423714 | Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease |
Q92151642 | Measles infection causing Bacillus Calmette-Guérin reactivation: a case report |
Q33853629 | Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. |
Q38828840 | Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. |
Q90666327 | MiR-182-5p enhances in vitro neutrophil infiltration in Kawasaki disease |
Q92617362 | MiR-197-3p regulates endothelial cell proliferation and migration by targeting IGF1R and BCL2 in Kawasaki disease |
Q57154331 | MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway |
Q88083249 | Mid-term Risk for Subclinical Atherosclerosis and Chronic Myocarditis in Children with Kawasaki Disease and Transient Coronary Abnormalities |
Q41838662 | Missed Kawasaki disease in childhood presenting as myocardial infarction in adults |
Q47282158 | Molecular basis of coronary artery dilation and aneurysms in patients with Kawasaki disease based on differential protein expression |
Q30369509 | Multimodality Cardiac Imaging in a Patient with Kawasaki Disease and Giant Aneurysms. |
Q58079436 | Multiomics analyses identified epigenetic modulation of the S100A gene family in Kawasaki disease and their significant involvement in neutrophil transendothelial migration |
Q111911746 | Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities |
Q38405051 | Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact |
Q40319114 | Mycoplasma pneumoniae infection in patients with Kawasaki disease |
Q64261888 | Myocardial fibrosis after adrenergic stimulation as a long-term sequela in a mouse model of Kawasaki disease vasculitis |
Q53724814 | Myocardial infarction in a 4-year-old child: role of echocardiography in diagnosis. |
Q40253880 | Myocardial strain and strain rate in Kawasaki disease |
Q90544457 | N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease |
Q38719434 | Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective |
Q43822577 | Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease |
Q40431662 | Nephromegaly in children with Kawasaki disease: new supporting evidence for diagnosis and its possible mechanism. |
Q64075568 | Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease |
Q89577552 | Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease |
Q64987492 | New Insight to the Pathogenetic Mechanism of Kawasaki Disease (KD): the Relationship between Clinical Diversity and Genetic Heterogeneity. |
Q33300097 | Noninvasive determination of endothelial cell function in the microcirculation in Kawasaki syndrome |
Q37983728 | Noninvasive imaging modalities and sudden cardiac arrest in the young: can they help distinguish subjects with a potentially life-threatening abnormality from normals? |
Q37324499 | Novel Echocardiographic Indices for Assessing the Left Main Coronary Artery in Children With Kawasaki Disease. |
Q30984727 | Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease |
Q30541810 | Novel finding of coronary ectasia in a case of acute rheumatic Fever. |
Q30846279 | Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children |
Q34065309 | Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature |
Q40219703 | Orbital cellulitis presenting as a first sign of incomplete kawasaki disease. |
Q90600240 | Orthostatic and Exercise Effects in Children Years After Kawasaki Disease |
Q54482946 | Orthotopic heart transplant for treatment-resistant cardiomyopathy in Kawasaki syndrome: report of a successful case. |
Q64093818 | Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days |
Q40179288 | Outcomes of Kawasaki Disease: A Single-Center Experience |
Q96168428 | Outcomes of Kawasaki disease with giant coronary aneurysms: a single-centre study in southwest China |
Q38546497 | Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease |
Q84049759 | Paediatric rheumatology: Corticosteroids as primary therapy in Kawasaki disease |
Q40314507 | Parameters to guide retreatment after initial intravenous immunoglobulin therapy in kawasaki disease |
Q40140080 | Patterns of Fever in Children After Primary Treatment for Kawasaki Disease |
Q37305538 | Pediatric Kawasaki Disease and Adult Human Immunodeficiency Virus Kawasaki-Like Syndrome Are Likely the Same Malady |
Q34991282 | Pediatric cardiac emergencies: Children are not small adults |
Q51362339 | Percutaneous coronary intervention for acute myocardial infarction in a pediatric patient with coronary aneurysm and stenosis due to Kawasaki disease. |
Q33958462 | Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease |
Q55381478 | Perianal skin peeling: An important clinical pointer toward Kawasaki disease. |
Q45787083 | Peribronchovascular haze: a frequently observed finding on chest X-rays in the acute phase of Kawasaki disease |
Q35688049 | Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients after Kawasaki Disease: A Systematic Review and Meta-Analyses |
Q24658305 | Periungual desquamation in patients with Kawasaki disease |
Q35576942 | Persistent fever in an infant: incomplete Kawasaki disease. |
Q60701323 | Phenotype and coronary outcome in Kawasaki's disease |
Q44283481 | Physical activity recommendations for patients with electrophysiologic and structural congenital heart disease: a survey of Canadian health care providers. |
Q36104063 | Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease. |
Q84743191 | Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease |
Q33729848 | Platelet Endothelial Cell Adhesion Molecule-1 Gene Polymorphisms are Associated with Coronary Artery Lesions in the Chronic Stage of Kawasaki Disease. |
Q82511806 | Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis |
Q33438988 | Point-of-care differentiation of Kawasaki disease from other febrile illnesses |
Q80729451 | Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease |
Q82100041 | Polymorphisms of transforming growth factor-β signaling pathway and Kawasaki disease in the Taiwanese population |
Q38676515 | Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores |
Q42678825 | Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease. |
Q40073906 | Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease |
Q51594255 | Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population. |
Q80079297 | Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment |
Q37634543 | Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease. |
Q40467858 | Predictive risk factors for coronary artery abnormalities in Kawasaki disease. |
Q37713300 | Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease |
Q40207614 | Predictors of coronary artery aneurysms in Kawasaki disease |
Q34497863 | Predictors of coronary artery visualization in Kawasaki disease |
Q40080910 | Predictors of diagnostic accuracy and safe management in difficult diagnostic problems in family medicine |
Q38923203 | Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease |
Q55365314 | Pregnancy in Woman with Kawasaki Disease and Multiple Coronary Artery Aneurysms. |
Q34145610 | Pregnancy in women with a history of Kawasaki disease: management and outcomes |
Q92424339 | Prescribing patterns of coronary artery aneurysm in Taiwan |
Q36086612 | Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia |
Q39399053 | Preventing coronary artery lesions in Kawasaki disease |
Q50555447 | Primary percutaneous coronary intervention for acute myocardial infarction due to possible sequelae of Kawasaki disease in young adults: a case series |
Q40803261 | Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease. |
Q35819600 | Profiles of responses of immunological factors to different subtypes of Kawasaki disease |
Q36375787 | Prolonged urticaria and fever in a toddler |
Q44581830 | Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population |
Q53699539 | Pseudo-normalization of a coronary artery aneurysm detected by IVUS. |
Q37018368 | Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype |
Q54682312 | Ptosis as a complication of Kawasaki disease. |
Q40197710 | Pulmonary Artery Dilation and Right Ventricular Function in Acute Kawasaki Disease |
Q37335438 | Pyuria associated with acute Kawasaki disease and fever from other causes |
Q38764634 | QT Dispersion and T Wave Peak-to-end Interval Dispersion in Children with Kawasaki Disease |
Q36236239 | Qing Re Liang Xue Decoction Alleviates Hypercoagulability in Kawasaki Disease |
Q30394049 | Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease |
Q26744310 | Radiological features of uncommon aneurysms of the cardiovascular system |
Q51185384 | Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada. |
Q28217527 | Re-treatment regimens for acute stage of Kawasaki disease patients who failed to respond to initial intravenous immunoglobulin therapy: analysis from the 17th nationwide survey |
Q38575942 | Recent Advances in Kawasaki Disease - Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014. |
Q54961260 | Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery. |
Q33765278 | Recognition of a Kawasaki disease shock syndrome |
Q40400914 | Recognition of kawasaki disease. |
Q55020028 | Recurrent Kawasaki disease: USA and Japan. |
Q34513089 | Recurrent fever syndromes in patients after recovery from Kawasaki syndrome |
Q91706456 | Refractory Kawasaki disease: diagnostic and management challenges |
Q40388893 | Refractory pneumonia and high fever |
Q54198415 | Regulatory T cell microRNA expression changes in children with acute Kawasaki disease. |
Q39782962 | Relationship between gallbladder distension and lipid profiles in kawasaki disease |
Q92407238 | Relationship between ocular involvement and clinical manifestations, laboratory findings, and coronary artery dilatation in Kawasaki disease |
Q36854706 | Resistance to intravenous immunoglobulin in children with Kawasaki disease |
Q43202462 | Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome |
Q41552267 | Retrospective analysis of risk factors associated with Kawasaki disease in China. |
Q94547418 | Reuma.pt/vasculitis - the Portuguese vasculitis registry |
Q38993829 | Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease |
Q50041746 | Review: surgical treatment of giant coronary aneurysms in pediatric patients with Kawasaki disease |
Q38948370 | Revisiting the role of environmental and climate factors on the epidemiology of Kawasaki disease. |
Q36426845 | Rifampin-warfarin interaction in a mitral valve replacement patient receiving rifampin for infective endocarditis: a case report |
Q55154327 | Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease. |
Q90706566 | Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis |
Q40399146 | Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. |
Q36854043 | Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease |
Q47589960 | Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method. |
Q36849601 | Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm |
Q50071875 | Role of intravenous immunoglobulin in the treatment of Kawasaki disease |
Q40030087 | Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population |
Q38704612 | ST-elevation myocardial infarction in a young adult secondary to giant coronary aneurysm thrombosis: an important sequela of Kawasaki disease and a management challenge |
Q47104522 | Safety netting versus overtreatment in paediatrics: viral infection or incomplete Kawasaki disease? |
Q36531763 | Salvianolic Acid B Down-regulates Matrix Metalloproteinase-9 Activity and Expression in Tumor Necrosis Factor-α-induced Human Coronary Artery Endothelial Cells |
Q41665077 | Screening of differentially expressed genes associated with Kawasaki disease by microarray analysis |
Q55049526 | Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. |
Q34994749 | Seasonality of Kawasaki disease: a global perspective |
Q36363661 | Sensorineural hearing loss in patients with Kawasaki disease |
Q90448458 | Serum IP-10 and IL-17 from Kawasaki disease patients induce calcification-related genes and proteins in human coronary artery smooth muscle cells in vitro |
Q34031949 | Serum brain natriuretic peptide in children with Kawasaki disease |
Q42155203 | Serum miR-200c and miR-371-5p as the Useful Diagnostic Biomarkers and Therapeutic Targets in Kawasaki Disease. |
Q99710925 | Serum proteins may facilitate the identification of Kawasaki disease and promote in vitro neutrophil infiltration |
Q37710599 | Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease |
Q53601864 | Severe desquamation in Kawasaki disease: Is it somehow protective? |
Q40918218 | Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? |
Q40041622 | Sex Differences in Pediatric Rheumatology. |
Q91228078 | Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study |
Q51500753 | Shock: an unusual presentation of Kawasaki disease. |
Q91909047 | Significance of Differential Characteristics in Infantile Kawasaki Disease |
Q40236353 | Sociodemographic profile of children with Kawasaki disease in North India |
Q53157295 | Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease. |
Q33851898 | Spatial and temporal clustering of Kawasaki syndrome cases |
Q59792948 | Spatiotemporal clustering of cases of Kawasaki disease and associated coronary artery aneurysms in Canada |
Q40338735 | Spectrum of kawasaki disease |
Q35799392 | Spontaneous closure of patent ductus arteriosus after an episode of Kawasaki disease: a case report |
Q42754568 | Stent implantation of left main coronary artery stenosis in an infant: Effective long-term treatment? |
Q46202051 | Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study |
Q38541112 | Stress echocardiography in paediatric cardiology |
Q40321637 | Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease |
Q36374231 | Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) |
Q38823957 | Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance. |
Q82205291 | Syndrome of inappropriate anti‐diuretic hormone in Kawasaki disease |
Q35040809 | Systematic confirmation study of GWAS-identified genetic variants for Kawasaki disease in a Chinese population |
Q64990650 | Systemic and pulmonary artery aneurysms in incomplete Kawasaki disease. |
Q80172901 | T cell activation profiles in Kawasaki syndrome |
Q36323375 | T-Helper Cytokine Profiles in Patients with Kawasaki Disease |
Q56759657 | TNF-α blockers for the treatment of Kawasaki disease in children |
Q36949286 | The Clinical Profile of Kawasaki Disease in Algerian Children: A Single Institution Experience |
Q36004589 | The Complexities of the Diagnosis and Management of Kawasaki Disease |
Q42368365 | The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease? |
Q64064159 | The Gene Polymorphisms rs16944 and rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease |
Q98290720 | The Importance of Serum N-Terminal Pro-Brain Natriuretic Peptide and Endogenous Hydrogen Sulfide for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease Patients: Findings From a Tertiary Care Hospital in Karachi, Pakistan |
Q35284683 | The Quality of Practice Committee of the RCPCH |
Q39838568 | The Xi'an Experience of Kawasaki Disease - Lessons Learnt over 5 years |
Q49329732 | The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease. |
Q89107272 | The association between the miR-146a rs2910164 C>G polymorphism and Kawasaki disease in a southern Chinese population |
Q33639687 | The clinical profile of Kawasaki disease of children from three Polish centers: a retrospective study |
Q42315522 | The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease |
Q54155405 | The emergence of Kawasaki disease in India and China. |
Q38537961 | The epidemiology of Kawasaki disease: a global update |
Q40283224 | The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976. |
Q37175810 | The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease |
Q53806066 | The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis. |
Q92236795 | The radial augmentation index in children with Kawasaki disease without acute coronary artery lesions during the convalescent period |
Q51733083 | The risk of hospitalization for respiratory tract infection (RTI) in children who are treated with high-dose IVIG in Kawasaki Disease: a nationwide population-based matched cohort study. |
Q36457051 | The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease |
Q33718942 | The roles of Ca2+/NFAT signaling genes in Kawasaki disease: single- and multiple-risk genetic variants |
Q97528185 | The rs1051931 G>A Polymorphism in the PLA2G7 Gene Confers Resistance to Immunoglobulin Therapy in Kawasaki Disease in a Southern Chinese Population |
Q58801947 | The rs1625579 T>G polymorphism in the gene confers a risk of early- onset Kawasaki disease in a southern Chinese population |
Q64262299 | The rs4919510 G>C polymorphism confers reduce coronary injury of Kawasaki disease in a Southern Chinese population |
Q26750499 | Therapeutic advances in the treatment of vasculitis |
Q39211874 | Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease |
Q46456444 | Thrombus in a coronary artery aneurysm shortly after warfarin withdrawal |
Q38695974 | Time to focus on outcome assessment tools for childhood vasculitis |
Q41216033 | Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease |
Q34088555 | Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance |
Q27025884 | Treatment of Kawasaki disease by different doses of immunoglobulin: a meta analysis of efficacy and safety |
Q35063963 | Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G |
Q98156924 | Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products |
Q51070610 | Two cases with past Kawasaki disease developing acute myocardial infarction in their thirties, despite being regarded as at low risk for coronary events. |
Q43714099 | Ultrasound tissue characterization of the myocardium in patients after Kawasaki disease |
Q40447374 | Unilateral cervical mass as a main clue raising the diagnostic suspicion of Kawasaki syndrome. |
Q39077552 | Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness |
Q40793680 | Unplanned Repeat Echocardiography with Sedation in Children: Patient Risk Factors |
Q64229355 | Unusual Presentation of Kawasaki Disease in a 13-year-old Saudi Boy |
Q28550044 | Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses |
Q36602116 | Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease |
Q36407658 | Usefulness of Neutrophil to Lymphocyte Ratio in Prediction of Coronary Artery Lesions in Patients with Kawasaki Disease |
Q83475021 | Usefulness of myocardial perfusion imaging with exercise testing in children |
Q35466181 | Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. |
Q38850359 | Using the Electronic Medical Record to Correlate Kawasaki Disease Phenotypes With Clinical Outcomes |
Q53755859 | Utility of adenosine stress perfusion CMR to assess paediatric coronary artery disease. |
Q97549100 | Validation of genome-wide associated variants for Kawasaki disease in a Taiwanese case-control sample |
Q38011899 | Variability in delivery of care and echocardiogram surveillance of Kawasaki disease |
Q60930481 | Variation in IL-21-secreting circulating follicular helper T cells in Kawasaki disease |
Q40292278 | Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children |
Q36181470 | Various coronary artery complications of Kawasaki disease: Series of 5 cases and review of literature. |
Q61452114 | Vascular imaging findings with high-pitch low-dose dual-source CT in atypical Kawasaki disease |
Q38259908 | Vasculitides and the Complement System: a Comprehensive Review |
Q38591612 | Vasculitis as an adverse event following immunization - Systematic literature review. |
Q91741001 | Vasculitis: A Checklist to Approach and Treatment Update for Dermatologists |
Q34074677 | Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase. |
Q53831299 | Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease. |
Q90013988 | Very Early Development and Recognition of Coronary Involvement in a Febrile Infant with Typical Signs of Kawasaki Disease |
Q53465808 | Visualization of coronary arteries in patients after childhood Kawasaki syndrome: value of multidetector CT and MR imaging in comparison to conventional coronary catheterization. |
Q46890541 | Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease |
Q33851902 | When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood |
Q55002256 | Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease. |
Q83819063 | Woven right and aneurysmatic left coronary artery associated with Kawasaki disease in a 9-month-old patient |
Q95511655 | [Changes in peripheral blood T helper 9 cells and interleukin-9 in children in the acute stage of Kawasaki disease] |
Q81532252 | [Corticoid use in the treatment of Kawasaki disease] |
Q81468921 | [Severe neonatal Kawasaki disease] |
Q95516467 | [Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease] |
Q38383813 | miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease. |
Q41379432 | L’acide acétylsalicylique pour les enfants atteints de la maladie de Kawasaki |
Search more.